The global Tissue Diagnostics market size is expected to be worth around US$ 6.6 billion by 2027, according to a new report by Vision Research Reports.
The global Tissue Diagnostics market size was valued at US$ 4.2 billion in 2019 and is anticipated to grow at a CAGR of 5.9% during forecast period 2020 to 2027. This industry is experiencing significant growth due to the rising incidence of cancer, developing infrastructure for cancer diagnosis, recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.
Tissue diagnostics continues to serve as one of the gold standards for cancer diagnosis as these technologies capture the biological context of tumors. With an increasing incidence of cancer, the market for tissue diagnostics has witnessed high demand with lucrative growth opportunities in the near future. Tissue diagnostic techniques are majorly used to understand the preserved antigens in specific tissues. Tissue diagnostics involves monitoring, diagnosis, and management of different stages of cancer, especially breast cancer, prostate cancer, and gastric cancer, among others.
Technology and Product Insights
Immunohistochemistry (IHC) is widely applied in clinical research and development of cancer diagnostics and therapeutics, resulting in the largest revenue share in 2020. IHC is largely preferred over conventional enzyme staining techniques as it specifically provides variations between different types of tumors. Whereas, the conventional methods detect only a restricted number of tissue structures, enzymes, and proteins of tumors.
Digital pathology is estimated to witness the fastest growth rate during the forecast period. An increase in the adoption rate of whole-slide imaging (WSI) among the pathologists, serves as one of the key factors driving the segment growth. WSI extracts specific features of tumors and quantifies each component of these features to further support the cancer diagnosis and provide informative clinical measures for tumors.
The breast cancer segment accounted for the largest share in terms of revenue in 2020 owing to high incidence rates of breast cancer globally, caused due to increase in inheritance and family history. Besides, several research initiatives coupled with the support of the government and private centers, further drive the development of effective products for the diagnosis of breast cancer. This, in turn, is surging the tissue diagnostics market for this application.
For instance, a research study published in March 2019 validated the CanAssist-Breast test. It is a prognostic immunohistochemistry test to predict recurrence risk in the early stages of hormone-receptor-positive breast carcinoma. This research was supported by Rajiv Gandhi Cancer Institute and Research Centre, Tata Memorial Centre, and Sapien Biosciences Pvt. Ltd. in India.
Remarkable progress in prostate cancer biomarker discovery due to advancements in genomic technologies has driven segment growth at a lucrative pace. The biomarker discovery has assisted the development of tissue diagnostic assays, thus providing opportunities for segment growth. Several diagnostic solutions for prostate cancer diagnosis are also available, such as immunohistochemistry (IHC) assays provided by Roche and NeoGenomics Laboratories.
Hospitals dominated the end-use segment in 2020, in terms of revenue generation, due to the high consumption and utility rates of tissue diagnostic solutions by hospitals. The physicians are increasingly switching to tissue-based diagnostic testing techniques from conventional testing procedures. This is because tissue diagnostic tests reduce timelines when compared to conventional methods.
Contract research organizations (CROs) are anticipated to witness lucrative growth. CROs provide research support, clinical trial services, manage trials, and functions of companies and healthcare providers, which face budget constraints. A rise in the number of clinical trials and extensive research studies in the field of cancer therapy has significantly driven the demand for services provided by CROs. This has accelerated the revenue generation for this segment.
The high incidence rate of cancer is one of the major factors attributive to the largest revenue share of North America. The presence of several public programs aims to minimize cancer incidence and raise the demand for cancer diagnosis supplements in the regional market for tissue diagnostics. The Cancer Prevention and Control Research Network is a flagship program by the Centers for Disease Control and Prevention that focuses on cancer prevention in this region.
Personalized medicine greatly relies on the use of human tissue for the development of innovative tests. An increase in the adoption of sequencing technologies and healthcare IT systems in the clinical workflow has significantly expanded personalized medicine, which further drives the usage of tissue diagnostics. The Precision Medicine Initiative in U.S. further expands the personalized medicine industry.
Asia Pacific is estimated to witness a lucrative growth rate in near future due to an increase in access to several tissue diagnostic assays provided by international companies. For instance, in April 2019, HalioDx SAS signed an agreement with Genecast for the commercialization of HalioDx’s Immunoscore diagnostic assay in China. This initiative increased the availability of this product for colon cancer patients in China.
Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
Hospitals accounted for the largest share of the tissue diagnostics market, globally
· What factors contribute to the high usage of tissue diagnostics by hospitals?
· Which region is expected to experience the fastest growth in the usage of tissue diagnostics in hospitals?
· How does the penetration of tissue diagnostics differ among other end users such as research laboratories, pharmaceutical companies, contract research organizations, and others?
Tissue diagnostics market favors both larger and local manufacturers that compete in multiple segments
· Who are the top competitors in this market and what strategies do they employ to gain shares?
· What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
· What strategies should new companies looking to enter in this market use to compete effectively?
· What are the major drivers, restraints, challenges, and opportunities in the tissue diagnostics market?
· Who are the major players in various countries and what share of the market do they hold?
· What are the geographical trends and high growth regions/ countries?
Recent partnerships, acquisitions, and expansions have taken place in the global tissue diagnostics market
· What companies have recently merged/acquired and how will these unions affect the competitive landscape of the tissue diagnostics market?
· What companies have created partnerships and how will these partnerships promote a competitive advantage?
· Who are the major players in the global tissue diagnostics market and what share of the market do they hold?
· What are the local emerging players in the global tissue diagnostics market and how do they compete with the global players?
Tissue Diagnostics Technology & Product Outlook
Slide Staining Systems
Tissue Processing Systems
In Situ Hybridization
Primary & Special Staining
Digital Pathology and Workflow
Whole Slide Imaging
Image Analysis Informatics
Information Management System Storage & Communication
Microtomes & Cryostat microtomes
Reagents & Antibodies
Probes & Kits
Tissue Diagnostics Application Outlook
Non-small Cell Lung Cancer
Tissue Diagnostics End-Use Outlook
Contract Research Organizations (CROs)
Tissue Diagnostics Regional Outlook
Middle East and Africa (MEA)
The Tissue Diagnostics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Tissue Diagnostics market for the base year 2020 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Tissue Diagnostics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tissue Diagnostics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Tissue Diagnostics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Tissue Diagnostics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Tissue Diagnostics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Tissue Diagnostics market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Tissue Diagnostics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Tissue Diagnostics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Tissue Diagnostics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Tissue Diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Tissue Diagnostics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Tissue Diagnostics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Tissue Diagnostics market. These factors have benefited the growth of the global market for Tissue Diagnostics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Tissue Diagnostics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Tissue Diagnostics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. In Vitro Diagnostics Market (By Product: Reagents, Instruments; By Technology: Immunoassay, Molecular Diagnostics; By Application: Infectious Diseases, Diabetes, Oncology, Cardiology; By End User: Hospitals, Laboratories, Home-care, Others) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
U.S. Clinical Trials Market (By Phase: Phase I, II, III, IV; By Study Design: Interventional, Observational; By Indication: Oncology, Diabetes) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Compounding Pharmacies Market (By Therapeutic Area: Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements; By Product: Oral, Liquid Preparations, Topical, Rectal, Others; By Application: Pediatric, Adult, Geriatric, Veterinary; By Compounding Type: PIA, CUPM, PDA; By Sterility: Sterile, Non-sterile; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...
Optical Imaging Systems Market (By Technology: Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy; By Product: Imaging Systems, Optical Imaging Software, Illumination Systems, Others; By Application: Pathological, Intraoperative; By End-use Outlook; By Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022 – 2030Read more...